Brussels, 19 December 2025 - EuropaBio is pleased to welcome Ribbon Bio as its newest member.

Headquarted in the heart of Europe in Austria, with a subsidiary in the US, Ribbon Bio delivers advanced algorithm-driven technology that produces innovative MiroSynthTM DNA molecules for scientific solutions that support both human and planetary health.

The company is committed to supporting EuropaBio’s policy priorities by sharing its experience in DNA synthesis innovation, biosecurity, and quality standards, helping to ensure that European regulations safeguard society while enabling scientific and industrial progress.

In joining EuropaBio, Ribbon Bio aims to strengthen collaboration within Europe’s biotechnology community and contribute to a shared vision for responsible innovation. The company is committed to engaging in key regulatory discussions, including the EU Biotech Act, and helping shape a balanced framework that promotes scientific excellence, industrial competitiveness, and sustainable growth.

Dr. Claire Skentelbery, Director General of EuropaBio, said: “Ribbon Bio is an excellent example of a fast-growing EU innovator and it is critical that they can anchor and grow within the EU. The EU Biotech Act will be pivotal to continued progress and we will bring their voice to the top of discussions.”

Jodi Barrientos, CEO at Ribbon Bio, said: "Biosecurity policy and regulation must be at the forefront of decision-making for all DNA synthesis providers, particularly as our industry continues to scale and diversify. Joining EuropaBio marks an important step in Ribbon Bio’s commitment to responsible innovation and active engagement in Europe’s biotechnology ecosystem, and we welcome the opportunity to contribute our expertise to regulatory discussions that safeguard biosecurity while enabling scientific and economic progress."

For more information, please visit ribbonbio.com